A large number of Janumet's salt change combination, which is commissioned and manufactured by Daewon Pharmaceutical, have been approved for items.

The MFDS applied for a diabetes complex by Jin Yang, Young Poong, Withus, and Neo Bio Korea Pharm on the 2nd. 8 items of Sitaglipin HCl+Metformin and Colloidal Silicon Dioxide have been approved. This drug is an aid to diet and exercise therapy to improve blood sugar control in patients with type 2 diabetes, and Daewon Pharmaceutical developed last year as a salt change to escape the original MSD Janumet (Sitagliptin HCl+Metformin) general for exclusive.

Since Daewon Pharmaceutical obtained permission on December 30 last year, 25 pharmaceutica